Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function ...
Collaboration with Columbia University demonstrates enhanced bioavailability and impact on mitochondrial function by BPM31510 'Quinomics' technology enables precise bioanalytical and spatial ...
With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a ...